PDF
Calendar
| 2026-02-20 | Year-end Report 2025 |
| 2025-11-14 | Quarterly Report 2025-Q3 |
| 2025-08-15 | Quarterly Report 2025-Q2 |
| 2025-05-16 | Quarterly Report 2025-Q1 |
| 2025-02-21 | Year-end Report 2024 |
| 2024-10-31 | Quarterly Report 2024-Q3 |
| 2024-10-21 | Extra General Meeting 2024 |
| 2024-08-23 | Quarterly Report 2024-Q2 |
| 2024-06-28 | Annual General meeting |
| 2024-05-29 | Quarterly Report 2024-Q1 |
| 2024-05-17 | Ex-date Ordinary Dividend CLS B 0.00 SEK |
| 2024-04-25 | Split CLS B 200:1 |
| 2024-02-23 | Year-end Report 2023 |
| 2023-11-17 | Quarterly Report 2023-Q3 |
| 2023-08-25 | Quarterly Report 2023-Q2 |
| 2023-06-29 | Annual General meeting |
| 2023-06-22 | Ex-date Ordinary Dividend CLS B 0.00 SEK |
| 2023-06-08 | Extra General Meeting 2023 |
| 2023-05-25 | Quarterly Report 2023-Q1 |
| 2023-02-23 | Year-end Report 2022 |
| 2022-11-22 | Extra General Meeting 2022 |
| 2022-11-17 | Quarterly Report 2022-Q3 |
| 2022-08-25 | Quarterly Report 2022-Q2 |
| 2022-06-29 | Ex-date Ordinary Dividend CLS B 0.00 SEK |
| 2022-06-28 | Annual General meeting |
| 2022-05-19 | Quarterly Report 2022-Q1 |
| 2022-02-24 | Year-end Report 2021 |
| 2021-11-18 | Quarterly Report 2021-Q3 |
| 2021-08-24 | Quarterly Report 2021-Q2 |
| 2021-06-29 | Ex-date Ordinary Dividend CLS B 0.00 SEK |
| 2021-06-28 | Annual General meeting |
| 2021-05-19 | Quarterly Report 2021-Q1 |
| 2021-03-31 | Extra General Meeting 2021 |
| 2021-02-26 | Year-end Report 2020 |
| 2020-11-19 | Quarterly Report 2020-Q3 |
| 2020-08-26 | Quarterly Report 2020-Q2 |
| 2020-06-12 | Ex-date Ordinary Dividend CLS B 0.00 SEK |
| 2020-06-11 | Annual General meeting |
| 2020-05-28 | Quarterly Report 2020-Q1 |
| 2020-02-28 | Year-end Report 2019 |
| 2019-11-21 | Quarterly Report 2019-Q3 |
| 2019-08-22 | Quarterly Report 2019-Q2 |
| 2019-06-12 | Ex-date Ordinary Dividend CLS B 0.00 SEK |
| 2019-05-17 | Annual General meeting |
| 2019-05-16 | Quarterly Report 2019-Q1 |
| 2019-03-18 | Extra General Meeting 2019 |
| 2019-02-14 | Year-end Report 2018 |
| 2018-11-22 | Quarterly Report 2018-Q3 |
| 2018-08-23 | Quarterly Report 2018-Q2 |
| 2018-06-20 | Annual General meeting |
| 2018-06-14 | Ex-date Ordinary Dividend CLS B 0.00 SEK |
| 2018-05-24 | Quarterly Report 2018-Q1 |
| 2018-05-18 | Extra General Meeting 2018 |
| 2018-02-22 | Year-end Report 2017 |
| 2017-11-16 | Quarterly Report 2017-Q3 |
| 2017-07-17 | Quarterly Report 2017-Q2 |
| 2017-06-28 | Ex-date Ordinary Dividend CLS B 0.00 SEK |
| 2017-06-27 | Annual General meeting |
| 2017-05-18 | Quarterly Report 2017-Q1 |
| 2017-01-31 | Year-end Report 2016 |
| 2017-01-20 | Extra General Meeting 2017 |
| 2016-11-17 | Quarterly Report 2016-Q3 |
| 2016-08-18 | Quarterly Report 2016-Q2 |
| 2016-06-16 | Annual General meeting |
| 2016-05-19 | Quarterly Report 2016-Q1 |
| 2016-02-21 | Year-end Report 2015 |
| 2015-11-19 | Quarterly Report 2015-Q3 |
| 2015-08-20 | Quarterly Report 2015-Q2 |
| 2015-06-12 | Ex-date Ordinary Dividend CLS B 0.00 SEK |
| 2015-06-11 | Annual General meeting |
| 2015-05-21 | Quarterly Report 2015-Q1 |
| 2015-02-23 | Year-end Report 2014 |
| 2014-11-14 | Quarterly Report 2014-Q3 |
| 2014-08-20 | Quarterly Report 2014-Q2 |
| 2014-06-18 | Ex-date Ordinary Dividend CLS B 0.00 SEK |
| 2014-06-17 | Annual General meeting |
| 2014-05-22 | Quarterly Report 2014-Q1 |
| 2014-02-24 | Year-end Report 2013 |
| 2013-11-22 | Quarterly Report 2013-Q3 |
| 2013-09-19 | Extra General Meeting 2013 |
| 2013-08-20 | Quarterly Report 2013-Q2 |
| 2013-06-10 | Ex-date Ordinary Dividend CLS B 0.00 SEK |
| 2013-06-07 | Annual General meeting |
| 2013-05-24 | Quarterly Report 2013-Q1 |
| 2013-02-25 | Year-end Report 2012 |
| 2012-11-23 | Quarterly Report 2012-Q3 |
| 2012-08-24 | Quarterly Report 2012-Q2 |
| 2012-06-08 | Ex-date Ordinary Dividend CLS B 0.00 SEK |
| 2012-06-07 | Annual General meeting |
| 2012-04-20 | Quarterly Report 2012-Q1 |
| 2012-01-09 | Year-end Report 2011 |
| 2012-01-04 | Extra General Meeting 2012 |
| 2011-11-21 | Quarterly Report 2011-Q3 |
| 2011-09-26 | Capital Market Day 2010 |
| 2011-08-22 | Quarterly Report 2011-Q2 |
| 2011-06-10 | Annual General meeting |
| 2011-05-20 | Quarterly Report 2011-Q1 |
| 2011-02-24 | Year-end Report 2010 |
| 2010-11-24 | Quarterly Report 2010-Q3 |
| 2010-08-25 | Quarterly Report 2010-Q2 |
| 2010-05-28 | Ex-date Ordinary Dividend CLS B 0.00 SEK |
| 2010-05-26 | Quarterly Report 2010-Q1 |
| 2010-02-26 | Year-end Report 2009 |
| 2009-11-30 | Quarterly Report 2009-Q3 |
Description
| Country | Sweden |
|---|---|
| List | First North Stockholm |
| Sector | Health care |
| Industry | Medical technology |
Lund, Sverige - Clinical Laserthermia Systems AB (publ) (CLS eller "Bolaget") har idag publicerat sin årsredovisning för 2023
Clinical Laserthermia Systems AB (publ) (CLS eller "Bolaget") har idag publicerat sin årsredovisning för 2023. Årsredovisningen finns tillgänglig på bolagets hemsida https://clinicallaser.se/ och är även bifogad detta pressmeddelande.
En engelsk version av årsredovisningen kommer att publiceras på bolagets hemsida i början av juli.
För mer information, vänligen kontakta:
Dan J Mogren, VD Clinical Laserthermia Systems AB
Telefon: +46 (0) 70-590 11 40
E-post: dan.mogren@clinicallaser.com
Om CLS
Clinical Laserthermia Systems AB (publ), utvecklar och säljer TRANBERG®|Thermal Therapy System och ClearPoint Prism Neuro Laser Therapy Systems med sterilt engångsmaterial, för minimalinvasiv behandling av cancertumörer och läkemedelsresistent epilepsi. Produkterna marknadsförs och säljs direkt eller via partners för bildstyrd laserablation samt används i studier för behandling med imILT®, bolagets interstitiella lasertermoterapi för immunstimulerande ablation med potentiell abskopal behandlingseffekt. CLS har sitt huvudkontor i Lund samt dotterbolag i Tyskland, USA och marknadsbolag i Singapore. CLS är noterat på Nasdaq First North Growth Market under symbolen CLS B. Certified adviser (CA) är FNCA Sweden AB.
Mer information om CLS finns på företagets webbplats: www.clinicallaser.se